Mutations in CDH2 has been widely studied in arrhythmogenic right ventricular cardiomyopathy (ARVC) (Mayosi et al., 2017), but the effects of APA of Cdh2 have not been reported and worth further study. The gene discussed is CDH2; the disease is arrhythmogenic right ventricular cardiomyopathy.